Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hoves, Sabine
40  Ergebnisse:
Personensuche X
?
1

Myeloid-T cell interplay and cell state transitions associa..:

Schlenker, Ramona ; Schwalie, Petra C. ; Dettling, Steffen...
Med.  5 (2024)  7 - p. 759-779.e7 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subse..:

Murgaski, Aleksandar ; Kiss, Máté ; Van Damme, Helena...
Cancer Research.  82 (2022)  20 - p. 3785-3801 , 2022
Link: https://doi.org/10.1158/..
 
?
3

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subse..:

Murgaski, Aleksandar ; Kiss, Máté ; Van Damme, Helena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574379/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

The Tumor Milieu Promotes Functional Human Tumor-Resident P..:

Maser, Ilona-Petra ; Hoves, Sabine ; Bayer, Christa...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
5

Optimized antiangiogenic reprogramming of the tumor microen..:

Kashyap, Abhishek S. ; Schmittnaegel, Martina ; Rigamonti, Nicolò...
Proceedings of the National Academy of Sciences of the United States of America.  117 (2020)  1 - p. 541-551 , 2020
Link: https://www.jstor.org/st..
 
?
6

Phase Ib study of anti-CSF-1R antibody emactuzumab in combi..:

Machiels, Jean-Pascal ; Gomez-Roca, Carlos ; Michot, Jean-Marie...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001153 , 2020
Link: https://doi.org/10.1136/..
 
?
7

Optimized antiangiogenic reprogramming of the tumor microen..:

Kashyap, Abhishek S ; Schmittnaegel, Martina ; Rigamonti, Nicolò...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955310/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
8

Phase Ib study of anti-CSF-1R antibody emactuzumab in combi..:

Machiels, Jean-Pascal ; Gomez-Roca, Carlos ; Michot, Jean-Marie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590375/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Phase Ib study of anti-CSF-1R antibody emactuzumab in combi..:

Dmitriy Zamarin ; Jean-Pierre Delord ; Carlos Gomez-Roca...
https://jitc.bmj.com/content/8/2/e001153.full.  , 2020
Link: https://doi.org/10.1136/..
 
?
10

Optimized antiangiogenic reprogramming of the tumor microen..:

Kashyap, Abhishek S ; Schmittnaegel, Martina ; Rigamonti, Nicolò...
https://boris.unibe.ch/146678/.  , 2020
Link: https://boris.unibe.ch/1..
 
?
11

The Tumor Milieu Promotes Functional Human Tumor-Resident P..:

Maser, Ilona-Petra ; Hoves, Sabine ; Bayer, Christa...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/14646.  , 2020
Link: https://opus4.kobv.de/op..
 
?
12

The Tumor Milieu Promotes Functional Human Tumor-Resident P..:

Ilona-Petra Maser ; Sabine Hoves ; Christa Bayer...
https://www.frontiersin.org/article/10.3389/fimmu.2020.02082/full.  , 2020
Link: https://doi.org/10.3389/..
 
?
13

Phase Ib study of anti-CSF-1R antibody emactuzumab in combi..:

Machiels, Jean-Pascal ; Gomez-Roca, Carlos ; Michot, Jean-Marie...
boreal:245842.  , 2020
Link: http://hdl.handle.net/20..
 
?
14

Optimized antiangiogenic reprogramming of the tumor microen..:

Kashyap, Abhishek S. ; Schmittnaegel, Martina ; Rigamonti, Nicolò...
Proceedings of the National Academy of Sciences.  117 (2019)  1 - p. 541-551 , 2019
Link: https://doi.org/10.1073/..
 
?
15

Characterizing responsive and refractory orthotopic mouse m..:

Hage, Carina ; Hoves, Sabine ; Ashoff, Mailin...
PLOS ONE.  14 (2019)  7 - p. e0219517 , 2019
Link: https://doi.org/10.1371/..
 
1-15